해외 소식

Corporate News

2017 · 2016 · 2015 · 2014 · 2013 ·
  • National "Future Day" was a busy time at Geistlich Pharma again this year. Around twenty girls and boys accompanied their parents to work on 9 November. In keeping with the slogan of “changing sides”, the children learned about gender-atypical careers and work areas. The highlight of the day offered something for everyone: going to the cleanroom visitors’ area and getting dressed up in genuine cleanroom suits was a good way of relaxing and having fun.

  • The 2017 EAO in Madrid with more than 4,000 participants was the perfect platform for the official launch of Geistlich Fibro-Gide®, the alternative to connective tissue grafts. Geistlich Biomaterials properly celebrated this event with its customers, paying tribute to 10 years of successful research.

  • On our blog: Dealing with peri-implantitis

    “The answer is education. We should all be able to diagnose and treat peri-implantitis”. With this statement, Prof. Stuart J. Froum, United States, summarizes his long-standing experience on this controversial topic in an interview on our blog www.regeneration-expert.com!

    > Read More

     

  • Soft-tissue management is the focus of the current issue of GEISTLICH NEWS. Once again outstanding experts shed light on this key topic in regenerative dentistry.

  • On our blog: Bisphosphonates: A contraindication for augmentations?

    Are bisphosphonates a contraindication for bone augmentation? Not all patients on anti-resorptive therapy have a high risk of osteonecrosis of the jaw. So, when is implantation possible, and what should a dentist consider? Prof. Bilal Al-Nawas, Germany, gives a thorough insight and shares his “dos and don’ts”. Discover more on our blog www.regeneration-expert.com!

    > Read More

  • In keeping with its mission to improve patients’ quality of life, Geistlich Biomaterials – the leading specialist in the field of dental, bone and tissue regeneration – launches its new product: Geistlich Fibro-Gide® - The alternative to connective tissue grafts.

  • Leading international clinicians discussed the future of regenerative dentistry with representatives of Geistlich Biomaterials at the Regeneration Leaders’ Meeting in June 2017: “Innovation in the field of regenerative dentistry”. Have a look at the inspiring movie from this year’s Regeneration Leaders’ Meeting.

  • On our blog: Sinus floor elevation - Risk management

    Sinus floor elevation – How can we predict and avoid complications arising from a perforation of the Schneiderian membrane? How should we deal with a perforated membrane? Adj. Prof. Dr. Michael R. Norton, United Kingdom, confides his tips to us. Discover more on our blog www.regeneration-expert.com!

    > Read more

  • Mucosal biopsies are required to obtain a definitive histological diagnosis of potentially malignant oral disorders. A current study shows that Geistlich Mucograft® is an effective option for circumventing the need for a graft from the hard palate.

  • The upcoming EAO congress from October 05th to 07th, 2017, in Madrid will open a new chapter in soft-tissue regeneration. Geistlich Biomaterials is going to launch a new product.

PRESS CONTACT
Mirjam_Kessler_140x140.jpg
Dr. Mirjam Kessler
Director Corporate Communications
Flickr

For printable images, please send an e-mail to mediageistlich.ch

YouTube

Geistlich Pharma AG - Channel­